Abstract:Abstract Background Denervation-induced muscle atrophy is complex disease involving multiple biological processes with unknown mechanisms. N6-methyladenosine (m6A) participates in skeletal muscle physiology by regulating multiple levels of RNA metabolism, but its impact on denervation-induced muscle atrophy is still unclear. Here, we aimed to explore the changes, functions, and molecular mechanisms of m6A RNA methylation during denervation-induced muscle atrophy. Methods During denervation-induced muscle atrophy, the m6A immunoprecipitation sequencing (MeRIP-seq) as well as enzyme-linked immunosorbent assay analysis were used to detect the changes of m6A modified RNAs and the involved biological processes. 3-deazidenosine (Daa) and R-2-hydroxyglutarate (R-2HG) were used to verify the roles of m6A RNA methylation. Through bioinformatics analysis combined with experimental verification, the regulatory roles and mechanisms of m6A RNA methylation had been explored. Results There were many m6A modified RNAs with differences during denervation-induced muscle atrophy, and overall, they were mainly downregulated. After 72 h of denervation, the biological processes involved in the altered mRNA with m6A modification were mainly related to zinc ion binding, ubiquitin protein ligase activity, ATP binding and sequence-specific DNA binding and transcription coactivator activity. Daa reduced overall m6A levels in healthy skeletal muscles, which reduced skeletal muscle mass. On the contrary, the increase in m6A levels mediated by R-2HG alleviated denervation induced muscle atrophy. The m6A RNA methylation regulated skeletal muscle mass through ubiquitin–proteasome pathway. Conclusion This study indicated that decrease in m6A RNA methylation was a new symptom of denervation-induced muscle atrophy, and confirmed that targeting m6A alleviated denervation-induced muscle atrophy.

Insights into the epitranscriptomic role of N6-methyladenosine on aging skeletal muscle

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

M6a Epitranscriptomic Regulation of Tissue Homeostasis During Primate Aging

Regulation of RNA N6-methyladenosine Modification and Its Emerging Roles in Skeletal Muscle Development.

The Potential Role of m6A RNA Methylation in the Aging Process and Aging-Associated Diseases

N6-Methyladenosine in Vascular Aging and Related Diseases: Clinical Perspectives.

Multifaceted Functions and Novel Insight Into the Regulatory Role of RNA N6-Methyladenosine Modification in Musculoskeletal Disorders.

Multifaceted Functions and Novel Insight into the Regulatory Role of RNA N6-Methyladenosine Modification in Musculoskeletal Disorders

m6A methylation: Critical roles in aging and neurological diseases

Regulatory role of RNA N-6-methyladenosine modifications during skeletal muscle development

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

m 6A methylation in cellular senescence of age-associated diseases

Epitranscriptomic M6a Modification in the Stem Cell Field and Its Effects on Cell Death and Survival.

The epitranscriptomic m6A RNA modification modulates synaptic function in ageing and in a mouse model of synucleinopathy

N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer’s disease

N6-Methyladenosine Methylation of mRNA in Cell Senescence

Aging through an epitranscriptomic lens

Epitranscriptome Changes in Neurodegenerative Diseases and the Potential Strategy for the Therapeutics

Altered m6A RNA methylation governs denervation-induced muscle atrophy by regulating ubiquitin proteasome pathway

N6-Methyladenosine in Cell-Fate Determination of BMSCs: From Mechanism to Applications

The roles of N6-methyladenosine methylation in the regulation of bone development, bone remodeling and osteoporosis